Scanogen

Windsor Mill, United States

Scanogen is a molecular diagnostic company.

$2.9M raised

Sep 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Scanogen raised?

Scanogen has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in September 2025.

Who are Scanogen's investors?

Scanogen's investors include National Institute of Allergy and Infectious Diseases.

Where is Scanogen headquartered?

Scanogen is headquartered in Windsor Mill, United States.

What does Scanogen do?

Scanogen is a molecular diagnostic company.

What stage is Scanogen at?

Scanogen is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"Scanogen — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/scanogen. Accessed July 3, 2026.

APA

VCBacked. (2025). Scanogen — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/scanogen

Wikipedia (cite web)

{{cite web |title=Scanogen — Funding & Investors |url=https://www.vcbacked.co/company/scanogen |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.